Warhound raises $200M for genetically engineered military dogs
Original: Warhound raises $200M to engineer war dogs and arm them with Anduril gear
Why This Matters
U.S. military dog supply is foreign-dependent; bioengineering could close that gap.
Warhound, co-founded by Ben Lamm and Palmer Luckey, exits stealth with $200M in funding from In-Q-Tel, Sequoia, and 8VC, valuing it at $1.2B. The startup plans to genetically engineer working dogs and equip them with Anduril hardware.
Warhound launched Thursday with $200 million in funding and a $1.2 billion valuation. The company is co-founded by Colossal Biosciences' Ben Lamm and Anduril's Palmer Luckey, with backing from In-Q-Tel, Sequoia, and 8VC.
The core pitch: over 80% of U.S. military working dogs are sourced from Europe, and fewer than half pass service qualification. Genetic predispositions — cancer, hip dysplasia, poor eyesight, muscle atrophy — wash out large portions of each training cohort.
Warhound's approach is two-pronged. On the biology side, Lamm's team is using Colossal's gene-editing technology on cell lines from top-performing breeds — Belgian Malinois and German Shepherds — stored in a biobank. The goal is to engineer dogs with improved health, longevity, speed, agility, and enhanced olfactory capabilities for tasks like bomb detection.
On the hardware side, Anduril will supply tech-enabled vests and goggles, giving handlers real-time data on dog status and battlefield situational awareness. Lamm described the Anduril layer as 'on top of the dog, not in the dog.' Luckey holds no equity in Warhound. Lamm told TechCrunch the two connected about a year ago at a conference before developing the concept together.